Skip to content
10-Q

Quarterly Report

INNOVUS PHARMACEUTICALS, INC.

0001437749-19-022728

← back to feed
Filed
Nov 14, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 13, 2019 2.76M sh
Capex Q3 2019 · Sep 30, 2019 $21K
Capex restated Q3 2019 · Sep 30, 2018 $176K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$1.87M
Operating Cash Flow restated Q3 2019 · Sep 30, 2018 −$5.59M
Short Term Debt Q3 2019 · Sep 30, 2019 $2.76M
Short Term Debt Q3 2019 · Dec 31, 2018 $3.07M
Stockholders Equity Q3 2019 · Sep 30, 2019 −$2M
Stockholders Equity Q3 2019 · Jun 30, 2019 $46K
Stockholders Equity Q3 2019 · Mar 31, 2019 $1.06M
Stockholders Equity Q3 2019 · Dec 31, 2018 $109K
Stockholders Equity restated Q3 2019 · Sep 30, 2018 $858K
Stockholders Equity Q3 2019 · Jun 30, 2018 $1.17M
Stockholders Equity Q3 2019 · Mar 31, 2018 $2.71M
Stockholders Equity restated Q3 2019 · Dec 31, 2017 $903K
Current Liabilities Q3 2019 · Sep 30, 2019 $8.74M
Current Liabilities Q3 2019 · Dec 31, 2018 $7.35M
Total Liabilities Q3 2019 · Sep 30, 2019 $11.51M
Total Liabilities Q3 2019 · Dec 31, 2018 $10.02M
Current Assets Q3 2019 · Sep 30, 2019 $4.35M
Current Assets Q3 2019 · Dec 31, 2018 $5.02M
Total Assets Q3 2019 · Sep 30, 2019 $9.51M
Total Assets Q3 2019 · Dec 31, 2018 $10.13M
Sga Expense Q3 2019 · Sep 30, 2019 $2.27M
Sga Expense Q3 2019 · Sep 30, 2019 $7.43M
Sga Expense restated Q3 2019 · Sep 30, 2018 $2.02M
Sga Expense restated Q3 2019 · Sep 30, 2018 $5.64M
Rd Expense Q3 2019 · Sep 30, 2019 $86K
Rd Expense Q3 2019 · Sep 30, 2019 $234K
Rd Expense restated Q3 2019 · Sep 30, 2018 $59K
Rd Expense restated Q3 2019 · Sep 30, 2018 $93K
Net Income Q3 2019 · Sep 30, 2019 −$2.24M
Net Income Q3 2019 · Sep 30, 2019 −$5.98M
Net Income Q3 2019 · Jun 30, 2019 −$1.76M
Net Income Q3 2019 · Mar 31, 2019 −$1.99M
Net Income restated Q3 2019 · Sep 30, 2018 −$2.45M
Net Income restated Q3 2019 · Sep 30, 2018 −$6.12M
Net Income Q3 2019 · Jun 30, 2018 −$1.84M
Net Income Q3 2019 · Mar 31, 2018 −$1.83M
Operating Income Q3 2019 · Sep 30, 2019 −$1.7M
Operating Income Q3 2019 · Sep 30, 2019 −$4.38M
Operating Income restated Q3 2019 · Sep 30, 2018 −$1.5M
Operating Income restated Q3 2019 · Sep 30, 2018 −$4.33M
Gross Profit Q3 2019 · Sep 30, 2019 $3.54M
Gross Profit Q3 2019 · Sep 30, 2019 $11.62M
Gross Profit Q3 2019 · Sep 30, 2018 $5.84M
Gross Profit Q3 2019 · Sep 30, 2018 $15.5M
Cost Of Revenue Q3 2019 · Sep 30, 2019 $2.22M
Cost Of Revenue Q3 2019 · Sep 30, 2019 $6.35M
Cost Of Revenue restated Q3 2019 · Sep 30, 2018 $1.54M
Cost Of Revenue restated Q3 2019 · Sep 30, 2018 $3.74M
Revenue Q3 2019 · Sep 30, 2019 $5.76M
Revenue Q3 2019 · Sep 30, 2019 $17.97M
Revenue Q3 2019 · Sep 30, 2018 $7.38M
Revenue Q3 2019 · Sep 30, 2018 $19.24M